Miraculins Announces Change to Board of Directors

WINNIPEG, MANITOBA--(Marketwired - Apr 21, 2014) - Miraculins Inc. (TSX-VENTURE:MOM) (the "Company"), a medical diagnostic company focused on acquiring, developing and commercializing diagnostic tests and risk assessment technologies for unmet clinical needs, announces today that David Eichler has stepped down from the Company's Board of Directors.

"The Board wishes to thank David for his effective contributions during his tenure as a director," said Harry Bloomfield Q.C., Chair of the Miraculins Board.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Miraculins Inc.Christopher J. MoreauPresident & CEO204-477-7599204-453-1546info@miraculins.comwww.miraculins.com

Miraculins Inc. (TSXV:MOM)
過去株価チャート
から 5 2024 まで 6 2024